Evommune, Inc.
- EVMN
- NYSE
- Biotechnology
- Inflammatory Disease Therapies
$5.22
Today +0.97%Quote Oct 19, 2026, 02:00 PM UTC
−44.82%over the last month
Max drawdown −46.4%From 1-month high −46.4%3 months −55.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$189.4M
Quote Oct 19
Next earnings
—
Data unavailable
Analyst target
$25.00
+378.9% from here
Floor
$4.57
12.4% below price
Where the price sits
5 analysts
Analyst range, low to high
$8.00$50.00
- Price $5.22
- Resistance $5.30
- Consensus $25.00
The price is right under resistance. Analysts' average target sits about 379% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EVMNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
48